The pharmaceutical giant named Jeffrey Legos the head of a division it is counting on to overcome investor pressure and grow ...

In mid-2024, the commercial president of Pfizer’s oncology unit Suneet Varma announced his retirement after 15 years with the ...

Receiving a breast cancer diagnosis is a life-changing moment, and the journey through treatment can often feel overwhelming. From managing ...

The American CEO of Swiss drugmaker Novartis on Friday warned that the United States' exit from the World Health Organization ...

Novartis said profit will rise this year as new medicines help offset competition from copycats of its best-selling drug.

Ad hoc announcement pursuant to Art. 53 LR Full year Net sales grew +12% (cc1, +11% USD) with core operating income1 up +22% (cc, +19% USD) Sales growth driven by continued strong performance ...

Roche Holding AG said profit will probably outpace sales growth this year as the Swiss drugmaker works to keep research costs ...

Novartis AG’s plan to sell its 70.6% stake in Novartis India is on track, CEO Vas Narasimhan confirmed at the World Economic Forum in Davos. Speaking to CNBC-TV18, he emphasised the company’s ...

Ontario Liberal MPP Adil Shamji said removing the Ontario Health atHome CEO was “long past due” but failed to address a deeper problem. “Home care should be the focus — not the footnote ...

According to the email, while the company looks for its next CEO, Stacie Herron, KE’s current chief legal and administrative officer will serve as interim chief operating officer. In a statement ...

Novartis' CEO Vas Narasimhan on Tuesday, January 21, said the company remains committed to India, but it will take at least another decade before the Indian pharmaceutical market matures enough to ...

By Marc Schneider Industry News Editor BMG has named Johannes von Schwarzkopf as chief strategy officer and executive board member, effective January 1. Reporting to CEO Thomas Coesfeld ...